1/1
2 files

Etrolizumab for the Treatment of Ulcerative Colitis and Crohn’s Disease: An Overview of the Phase 3 Clinical Program

figure
posted on 29.10.2020, 10:36 by William J. Sandborn, Severine Vermeire, Helen Tyrrell, Azra Hassanali, Stuart Lacey, Swati Tole, Amanda R. Tatro, on behalf of the etrolizumab Global Steering Committee

The above summary slide and video represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.


History

Exports